Company profile for Clearside Biomedical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Clearside’s proprietary SCS Microinjector™ targeting the suprachoroidal space (SCS) offers unique access to the macula, retina and choroid where sight-threatening disease often occurs. The Company’s SCS injection platform is an inher...
Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Clearside’s proprietary SCS Microinjector™ targeting the suprachoroidal space (SCS) offers unique access to the macula, retina and choroid where sight-threatening disease often occurs. The Company’s SCS injection platform is an inherently flexible, in-office, non-surgical procedure, intended to provide targeted delivery to the site of disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
900 North Point Parkway, Suite 200 Alpharetta, GA 30005
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/24/3193383/0/en/Clearside-Biomedical-to-Pursue-Strategic-Sale-of-its-Business-Through-Voluntary-Chapter-11-Process.html

GLOBENEWSWIRE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/08/26/3139241/0/en/Clearside-Biomedical-Announces-Multiple-Presentations-on-Suprachoroidal-Delivery-to-be-Featured-at-the-25th-EURETINA-Congress.html

GLOBENEWSWIRE
26 Aug 2025

https://www.globenewswire.com/news-release/2025/07/23/3120111/0/en/Clearside-Biomedical-Announces-Approval-of-XIPERE-Suprachoroidal-Treatment-for-Uveitic-Macular-Edema-in-Canada.html

GLOBENEWSWIRE
23 Jul 2025

https://www.globenewswire.com/news-release/2025/07/17/3117105/0/en/Clearside-Biomedical-Announces-Plan-to-Explore-Strategic-Alternatives-to-Advance-its-Proprietary-Suprachoroidal-Space-SCS-Delivery-Platform-and-Promising-Ophthalmology-Pipeline.html

GLOBENEWSWIRE
17 Jul 2025

https://www.globenewswire.com/news-release/2025/06/17/3100534/0/en/Clearside-Biomedical-Announces-Multiple-Presentations-to-be-Featured-at-the-Clinical-Trials-at-the-Summit-Meeting.html

GLOBENEWSWIRE
17 Jun 2025

https://www.globenewswire.com/news-release/2025/05/21/3085610/0/en/Clearside-Biomedical-to-Participate-in-a-Fireside-Chat-at-the-Stifel-2025-Virtual-Ophthalmology-Forum.html

GLOBENEWSWIRE
21 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty